Navigation Links
GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
Date:2/23/2011

humoral (antibody) and cellular (cytotoxic T cell) immune responses, as well as, the vaccines' safety. Successful results from Phase 1 testing supported the initiation of the first Phase 2 testing. GeoVax's Phase 2 human trial began in January 2009 and will ultimately involve 300 participants at sites in the United States and South America. Recently GeoVax began enrolling patients in a Phase 1 therapeutic trial for individuals already infected with HIV. For more information, please visit www.geovax.com.

About the HVTNThe HIV Vaccine Trials Network (HVTN) is the largest worldwide clinical trials network dedicated to the development and testing of HIV/AIDS vaccines. The HVTN is an international collaboration that conducts all phases of clinical trials, from evaluating experimental vaccines for safety and the ability to stimulate immune responses, to testing vaccine efficacy. Support for the HVTN comes from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH). The Network's HIV Vaccine Trial Units are located at leading research institutions in 27 cities on four continents. The Network's headquarters are at the Fred Hutchinson Cancer Research Center in Seattle, Washington.

Forward-Looking Statements

Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether:  GeoVax can develop and manufacture its vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
2. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
3. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
4. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
5. GeoVax Labs Engages The Investor Relations Group
6. GeoVax Labs, Inc. Reports Fourth Quarter and Year End 2009 Financial Results
7. GeoVax Labs, Inc. Plans Public Offering
8. GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA
9. FDA Grants GeoVax Labs, Inc. Request For Pre-IND Meeting
10. GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update
11. GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... and RALEIGH, N.C. , ... Communications, LLC (CTMC), and Integrated Clinical Trial Services, ... and retention for clinical trials announce that they ... Trial Marketing Services (i-CTMS). i-CTMS will provide a ... to pharmaceutical, biotechnology and medical device companies. ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... of the "Electrocardiogram (ECG) Devices - Global Trends, ... http://photos.prnewswire.com/prnh/20130307/600769 ... US$330 million by 2016. The North America ... global market share while Europe ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  Immune ... announced today that its Board of Directors has elected Mr. ... Teper who continues as Chief Executive Officer of Immune. ... Directors since 2013. Immune,s new Chairman, Mr. ... interest of shareholders and to continue to support the strategic ...
Breaking Medicine Technology:Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4
... March 9 Cardium Therapeutics (NYSE Alternext US: ... today reported that positive clinical findings demonstrating faster ... techniques during robotic-assisted radical prostatectomy surgery will be ... Urology and is now available online at ...
... 900-mcg Albuferon (albinterferon alfa-2b) dosed every two weeks ... response comparable to peginterferon alfa-2a dosed weekly in ... - Patients receiving 900-mcg Albuferon had comparable rates ... alfa-2a -- Filing of global marketing applications planned ...
Cached Medicine Technology:Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 2Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 3Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 4Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 5Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 6Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 7Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 8Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 2Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 3Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 4Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 5Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 6Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 7Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 8Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 9Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 10
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... several different surgical procedures designed to assist weight loss by ... they absorb during digestion. It has been used for several ... in the journal Clinical Obesity reveals that bariatric ... adolescents., Led by Ange Aikenhead of the International Association for ...
... computers to understand inputs from humans that go beyond the ... and computer vision tries to make using computers easier," says ... comfortable, intuitive and intelligent way to use the computer? It ... also help disabled people use computers the way everyone else ...
... , FRIDAY, March 4 (HealthDay News) -- ... X-rays, ultrasounds, PET and CT scans to receive advanced ... amenable to extra tumor biopsies, according to a new ... with advanced cancer suggests a promising future for personalized ...
... 4, 2011) From its involvement in a healthy immune ... essential mineral for the human body. Zinc deficiency is a ... U.S. alone. Consumed naturally in the human diet, ... yogurt, eggs, and fish. Furthermore, zinc is widely used in ...
... animals use sex chromosomes to determine sex. In fruit ... and XY for males. Cellular mechanisms then kick into ... in females and males. Victoria Meller, Ph.D., ... Woods, Mich., received $301,392 from the National Institute of ...
... , FRIDAY, March 4 (HealthDay News) -- Poor ... of people worldwide at risk for early death, a ... treatment and management in Colombia, England, Iran, Mexico, Scotland, ... of U.S. adult diabetics -- more than 16 million ...
Cached Medicine News:Health News:Researchers use human cues to improve computer user-friendliness 2Health News:Researchers use human cues to improve computer user-friendliness 3Health News:Extra Tests Not a Deterrent to Experimental Cancer Therapy 2Health News:The tooth about zinc 2Health News:WSU study may lead to greater understanding of human genome regulation 2Health News:Diabetes Often Not Diagnosed or Treated Properly 2
Quantel Medical introduces the new Aviso A/B, a new generation high definition ultrasound system in a unique laptop or desktop PC workstation....
... The Paradigm LD400 FT is an affordable ... exam time by at least 40%. It has ... It features rapid setup and easy two-button operation ... friendly. The LD 400 FT is the workhorse ...
... Clear Corneal Diamond Knife is a unique ... Shepard of Santa Maria, California. This special ... need for a quality instrument that could ... Surgical technique. Through professional collaboration between KOI ...
... The Boomerang ClosureWire Vascular Closure ... called Arteriotomy Site-Specific Compression., ,The Boomerang ... between the inside of the arteriotomy ... resulting in a targeted internal compression ...
Medicine Products: